Literature DB >> 18705894

Ischemic perinatal stroke: challenge and opportunities.

Tonse N K Raju1.   

Abstract

The second highest risk group for developing a cerebral stroke is the perinatal period, generally defined as 20 weeks of gestation through 28th postnatal day of age. In this commentary, a brief overview of ischemic perinatal strokes is presented. Ischemic perinatal stroke (IPS) occurs at a rate of 1 : 2300 to 1 : 5000 births, accounting for 30% of children with hemiplegic cerebral palsy (CP). Thus, IPS is the most common known cause for CP [1-3]. Although they occur frequently, much remains to be studied about perinatal strokes in general and the ischemic variety in particular.

Entities:  

Mesh:

Year:  2008        PMID: 18705894     DOI: 10.1111/j.1747-4949.2008.00205.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  6 in total

Review 1.  Baby STEPS: a giant leap for cell therapy in neonatal brain injury.

Authors:  Cesar V Borlongan; Michael D Weiss
Journal:  Pediatr Res       Date:  2011-07       Impact factor: 3.756

2.  ADVANCES IN THE CELL-BASED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY.

Authors:  Mibel M Pabon; Cesar V Borlongan
Journal:  Future Neurol       Date:  2013-03-01

Review 3.  Advancing critical care medicine with stem cell therapy and hypothermia for cerebral palsy.

Authors:  Travis Dailey; Yusef Mosley; Mibel Pabon; Sandra Acosta; Naoki Tajiri; Harry van Loveren; Yuji Kaneko; Cesar V Borlongan
Journal:  Neuroreport       Date:  2013-12-18       Impact factor: 1.837

4.  Risk Factors for Perinatal Arterial Ischemic Stroke: A Case-Control Study.

Authors:  Daniela Munoz; María José Hidalgo; Fernanda Balut; Mónica Troncoso; Susana Lara; Andrés Barrios; Patricia Parra
Journal:  Cell Med       Date:  2018-07-11

5.  Mendelian etiologies identified with whole exome sequencing in cerebral palsy.

Authors:  Maya Chopra; Dustin L Gable; Jamie Love-Nichols; Alexa Tsao; Shira Rockowitz; Piotr Sliz; Elizabeth Barkoudah; Lucia Bastianelli; David Coulter; Emily Davidson; Claudio DeGusmao; David Fogelman; Kathleen Huth; Paige Marshall; Donna Nimec; Jessica Solomon Sanders; Benjamin J Shore; Brian Snyder; Scellig S D Stone; Ana Ubeda; Colyn Watkins; Charles Berde; Jeffrey Bolton; Catherine Brownstein; Michael Costigan; Darius Ebrahimi-Fakhari; Abbe Lai; Anne O'Donnell-Luria; Alex R Paciorkowski; Anna Pinto; John Pugh; Lance Rodan; Eugene Roe; Lindsay Swanson; Bo Zhang; Michael C Kruer; Mustafa Sahin; Annapurna Poduri; Siddharth Srivastava
Journal:  Ann Clin Transl Neurol       Date:  2022-01-24       Impact factor: 4.511

Review 6.  Stem cell therapy for neonatal hypoxic-ischemic encephalopathy.

Authors:  Gabriel S Gonzales-Portillo; Stephanny Reyes; Daniela Aguirre; Mibel M Pabon; Cesar V Borlongan
Journal:  Front Neurol       Date:  2014-08-12       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.